Erasca (ERAS)
(Delayed Data from NSDQ)
$1.50 USD
+0.10 (7.14%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.51 +0.01 (0.67%) 4:22 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Erasca, Inc. has a market cap of $396.60M, which represents its share price of $1.40 multiplied by its outstanding shares number of 283.29M. As a small-cap company, ERAS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ERAS 1.50 +0.10(7.14%)
Will ERAS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ERAS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ERAS
VKTX's Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10%
Merck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 View
ERAS: What are Zacks experts saying now?
Zacks Private Portfolio Services
PFE Stock Rises on Reports of Averting Proxy Fight With Activist Investor
Down -25.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)
AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer
Other News for ERAS
Erasca Confirms Directors and Ratifies KPMG Appointment
Erasca (ERAS) Gains FDA Clearance for Innovative KRAS Inhibitor | ERAS Stock News
Erasca announces IND clearance for ERAS-4001
Erasca announces IND clearance for ERAS-4001
Erasca GAAP EPS of -$0.11